Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

Share Price Information for De La Rue (DLAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 95.20
Bid: 95.00
Ask: 96.40
Change: -1.00 (-1.04%)
Spread: 1.40 (1.474%)
Open: 93.40
High: 95.20
Low: 93.40
Prev. Close: 96.20
DLAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

APPOINTMENT OF CHIEF EXECUTIVE

13 Dec 2010 07:00

RNS Number : 7953X
De La Rue PLC
13 December 2010
 



 

 

 

 

 

13 December 2010

 

DE LA RUE ANNOUNCES TIM COBBOLD'S APPOINTMENT

AS CHIEF EXECUTIVE FROM 1 JANUARY 2011

 

De La Rue Plc ("De La Rue") is pleased to announce the appointment of Tim Cobbold as Chief Executive and an executive director of the Company with effect from 1 January 2011.

 

Tim has over twenty years of international management experience in manufacturing industries. He joins De La Rue from Chloride Group PLC, an international provider of secure power solutions, which has recently been taken over by Emerson Electric Co. Tim joined Chloride in 2007 as Chief Operating Officer and became CEO in 2008. Prior to this, he had been with Smiths Group PLC since 1989 holding a wide variety of senior roles including a number of Managing Director positions. Tim is a chartered accountant and is a non-executive Director of Drax Group plc.

 

As previously announced, Nicholas Brookes will resume his position as non-executive Chairman and Colin Child will revert to his Group Finance Director role once Tim joins the Company.

 

Commenting on Tim's appointment, Nicholas Brookes said:

 

"We are delighted that Tim will be joining De La Rue as Chief Executive on 1 January. There is no doubt about the regard in which Tim is held. His wealth of experience, including of international business at the most senior level, will be invaluable to De La Rue both in the short term as we work to resolve current uncertainties and in the longer term as we continue to build our global brand and international customer base."

 

Tim Cobbold said:

 

"De La Rue has a long established reputation as a global leader in an industry with unique characteristics. I look forward, with the rest of the Board, to demonstrating De La Rue's fundamental value by building on its core strengths as an independent company and growing value for its shareholders. I look forward to working with the experienced team at De La Rue to strengthen the business and deliver on its potential as the industry leader."

 

There is nothing which is required to be disclosed under Listing Rules 9.6.13 in respect of Tim Cobbold other than as disclosed above.

 

-ends-

 

 

For further information please contact:

 

Nicholas Brookes Executive Chairman +44(0)1256 605000

Colin Child Chief Operating Officer and

Group Finance Director

 

Jon Coles Brunswick +44 (0) 207 404 5959

Kate Holgate

 

 

 

Notes

 

De La Rue is the world's largest commercial security printer and papermaker, involved in the production of over 150 national currencies and a wide range of security documents such as passports, authentication labels and fiscal stamps. The company is a leading provider of cash sorting equipment and software solutions to Central Banks, helping them to reduce the cost of handling cash. De La Rue also pioneers new technologies in government identity solutions for national identification, driver's licence and passport issuing schemes. De La Rue employs approximately 4,000 people worldwide and is a member of the FTSE 250.

 

For more information, please visit www.delarue.com

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFFSFUEFSSELE
Date   Source Headline
30th May 20247:00 amRNSStrategic Update
2nd May 202411:39 amRNSHolding(s) in Company
17th Apr 20247:00 amRNSPre-Close Trading Statement
16th Apr 202411:52 amRNSHolding(s) in Company
16th Apr 202410:59 amRNSHolding(s) in Company
3rd Apr 20247:00 amRNSExtension of contract with Microsoft
2nd Apr 202411:25 amRNSTotal Voting Rights
7th Mar 20241:04 pmRNS2023 AGM Voting Update
23rd Feb 20242:06 pmRNSAdditional Listing
29th Jan 20244:14 pmRNSHolding(s) in Company
26th Jan 20244:38 pmRNSDirector/PDMR Shareholding
18th Jan 20243:19 pmRNSHolding(s) in Company
18th Jan 202412:13 pmRNSHolding(s) in Company
2nd Jan 202411:33 amRNSBlock listing Interim Review
21st Dec 20233:51 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNS2023/24 half year results
27th Nov 20232:53 pmRNSHolding(s) in Company
1st Nov 20231:51 pmRNSTotal Voting Rights
30th Oct 202311:05 amRNSHolding(s) in Company
13th Oct 202310:27 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSPre-close Trading Statement
2nd Oct 202311:47 amRNSTotal Voting Rights
20th Sep 202312:59 pmRNSDirector/PDMR Shareholding
13th Sep 20231:09 pmRNSHolding(s) in Company
7th Sep 20231:59 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM statement and trading update
4th Sep 202312:36 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
14th Aug 20233:30 pmRNSHolding(s) in Company
11th Aug 20232:58 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSDirectorate Change
4th Aug 20237:00 amRNSDirectorate Change
3rd Aug 20239:21 amRNSAppointment of Joint Broker
2nd Aug 20233:26 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 20231:44 pmRNSDirector/PDMR Shareholding
24th Jul 20233:04 pmRNSHolding(s) in Company
20th Jul 20234:03 pmRNSHolding(s) in Company
20th Jul 202312:17 pmRNSAnnual Financial Report
19th Jul 20231:01 pmRNSHolding(s) in Company
11th Jul 202310:28 amRNSDirector/PDMR Shareholding
4th Jul 202312:59 pmRNSHolding(s) in Company
3rd Jul 20235:44 pmRNSHolding(s) in Company
3rd Jul 202312:12 pmRNSBlock listing Interim Review
3rd Jul 202312:09 pmRNSTotal Voting Rights
30th Jun 20231:40 pmRNSHolding(s) in Company
30th Jun 20231:35 pmRNSHolding(s) in Company
30th Jun 202310:11 amRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFY23 full year results
28th Jun 20235:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.